<sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antim...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2013-01-01
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039 |
id |
doaj-c800a2604e3f492aa453905eb04bc88b |
---|---|
record_format |
Article |
spelling |
doaj-c800a2604e3f492aa453905eb04bc88b2020-11-24T23:43:16ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical0037-86821678-98492013-01-014613944Michel Rodrigues MoreiraMunick Paula GuimarãesAurélia Aparecida de Araújo RodriguesPaulo Pinto Gontijo Filho<sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antimicrobial usage, incidence, etiology, and antimicrobial resistance trends for prominent nosocomial pathogens causing ventilator-associated pneumonia in a clinical-surgical intensive care unit (ICU). </sec><sec><title>METHODS</title>: Gram-negative bacilli and Staphylococcus aureus causing VAP, as well as their antimicrobial resistance patterns and data on consumption (defined daily dose [DDD] per 1,000 patient days) of glycopeptides, extended-spectrum cephalosporins, and carbapenems in the unit were evaluated in two different periods (A and B). </sec><sec><title>RESULTS:</title> Antimicrobial use was high, mainly of broad-spectrum cephalosporins, with a significant increase in the consumption of glycopeptides (p < 0.0001) and carbapenems (p < 0.007) in period B. For Acinetobacter baumannii and members of the Enterobacteriaceae family, 5.27- and 3.06-fold increases in VAPs, respectively, were noted, and a significant increase in resistance rates was found for imipenem-resistant A. baumannii (p = 0.003) and third-generation cephalosporins-resistant Enterobacteriaceae (p = 0.01) isolates in this same period. </sec><sec><title>CONCLUSIONS:</title> Our results suggest that there is a link between antibiotics usage at institutional levels and resistant bacteria. The use of carbapenems was related to the high rate of resistance in A. baumannii and therefore a high consumption of imipenem/meropenem could play a major role in selective pressure exerted by antibiotics in A. baumannii strains.</sec>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039Antibiotic consumptionIntensive care unitVentilator-associated pneumoniaAntimicrobial resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michel Rodrigues Moreira Munick Paula Guimarães Aurélia Aparecida de Araújo Rodrigues Paulo Pinto Gontijo Filho |
spellingShingle |
Michel Rodrigues Moreira Munick Paula Guimarães Aurélia Aparecida de Araújo Rodrigues Paulo Pinto Gontijo Filho Revista da Sociedade Brasileira de Medicina Tropical Antibiotic consumption Intensive care unit Ventilator-associated pneumonia Antimicrobial resistance |
author_facet |
Michel Rodrigues Moreira Munick Paula Guimarães Aurélia Aparecida de Araújo Rodrigues Paulo Pinto Gontijo Filho |
author_sort |
Michel Rodrigues Moreira |
publisher |
Sociedade Brasileira de Medicina Tropical (SBMT) |
series |
Revista da Sociedade Brasileira de Medicina Tropical |
issn |
0037-8682 1678-9849 |
publishDate |
2013-01-01 |
description |
<sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antimicrobial usage, incidence, etiology, and antimicrobial resistance trends for prominent nosocomial pathogens causing ventilator-associated pneumonia in a clinical-surgical intensive care unit (ICU). </sec><sec><title>METHODS</title>: Gram-negative bacilli and Staphylococcus aureus causing VAP, as well as their antimicrobial resistance patterns and data on consumption (defined daily dose [DDD] per 1,000 patient days) of glycopeptides, extended-spectrum cephalosporins, and carbapenems in the unit were evaluated in two different periods (A and B). </sec><sec><title>RESULTS:</title> Antimicrobial use was high, mainly of broad-spectrum cephalosporins, with a significant increase in the consumption of glycopeptides (p < 0.0001) and carbapenems (p < 0.007) in period B. For Acinetobacter baumannii and members of the Enterobacteriaceae family, 5.27- and 3.06-fold increases in VAPs, respectively, were noted, and a significant increase in resistance rates was found for imipenem-resistant A. baumannii (p = 0.003) and third-generation cephalosporins-resistant Enterobacteriaceae (p = 0.01) isolates in this same period. </sec><sec><title>CONCLUSIONS:</title> Our results suggest that there is a link between antibiotics usage at institutional levels and resistant bacteria. The use of carbapenems was related to the high rate of resistance in A. baumannii and therefore a high consumption of imipenem/meropenem could play a major role in selective pressure exerted by antibiotics in A. baumannii strains.</sec> |
topic |
Antibiotic consumption Intensive care unit Ventilator-associated pneumonia Antimicrobial resistance |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039 |
_version_ |
1725502336226295808 |